Friday, 14 Dec 2018

David Liew

About this author

David Liew, FRACP is in clinical practice at Austin Health, Melbourne, Australia and is also a research fellow in the Department of Clinical Pharmacology and Therapeutics at the same institution. His areas of interest include immune-related adverse events from checkpoint inhibitors and polymyalgia rheumatica. Follow him on Twitter: @drdavidliew.